Arvanitis, M., Koch, C. M., Chan, G. G., Arancivia, C. M., LaValley, M., Jacobson, D., . . . Ruberg, F. L. (2017). Identification of V122I (Val122Ile) transthyretin cardiac amyloidosis (ATTR) using serum retinol-binding protein 4 (RBP4) and a clinical prediction model. JAMA Cardiol.

Arvanitis, Marios, Clarissa M. Koch, Gloria G. Chan, Celia M.T Arancivia, Michael LaValley, Daniel Jacobson, John L. Berk, Lawreen H. Connors, and Frederick L. Ruberg. "Identification of V122I (Val122Ile) Transthyretin Cardiac Amyloidosis (ATTR) Using Serum Retinol-binding Protein 4 (RBP4) and a Clinical Prediction Model." JAMA Cardiol 2017.

Arvanitis, Marios, et al. "Identification of V122I (Val122Ile) Transthyretin Cardiac Amyloidosis (ATTR) Using Serum Retinol-binding Protein 4 (RBP4) and a Clinical Prediction Model." JAMA Cardiol 2017.